Sponsored by:

Nuclear Medicine: Page 330

Canadian Senate OKs Chalk River restart
By AuntMinnie.com staff writers
The Senate in Canada's Parliament last night approved legislation to restart the Chalk River nuclear reactor, which manufactures radioisotopes for nuclear medicine applications.
December 12, 2007
MU seeks funds for new molybdenum-99 source
By AuntMinnie.com staff writers
The Missouri University Research Reactor (MURR) Center is hoping to become a U.S. supplier of molybdenum-99 (Mo-99), aiming to reduce reliance on foreign sources for the base isotope for technetium-99m.
December 11, 2007
Cellectar opens new facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Cellectar has opened a new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison, WI.
December 11, 2007
Cellectar opens new facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Cellectar has opened a new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison, WI.
December 10, 2007
ACR advises on Tc-99m shortage
By AuntMinnie.com staff writers
The Reston, VA-based American College of Radiology (ACR) says "severe cutbacks" are occurring in nuclear cardiology with the loss of more than 50% of the North American molybdenum-99 (Mo-99) supply, due to the prolonged shutdown of the Chalk River nuclear reactor in Ottawa, Canada.
December 10, 2007
AMIC speeds up launch date for technetium generators
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope (AMIC) said that it is accelerating the launch of its compact generator systems and technology in response to the extended shutdown of a Canadian reactor producing the base isotope for technetium-99m.
December 10, 2007
Gamma Medica notches sale to Louisiana health center
By AuntMinnie.com staff writers
Gamma camera developer Gamma Medica-Ideas of Northridge, CA, has sold one of its Flex Triumph multimodality preclinical molecular imaging systems to Louisiana State University Health Sciences Center in Shreveport.
December 6, 2007
Warning issued on radioisotope supply
By Wayne Forrest
Radioisotope maker Atomic Energy of Canada Ltd.'s (AECL) National Research Universal reactor in Chalk River, Ontario, will be offline for at least one more month, leaving hundreds of thousands of medical tests worldwide in jeopardy.
December 5, 2007
Bristol-Myers Squibb to divest imaging unit, including Cardiolite radiopharmaceutical
By Brian Casey
Pharmaceutical giant Bristol-Myers Squibb is planning to sell off its medical imaging unit as part of a restructuring of the New York City-based company. The firm's medical imaging division markets the Cardiolite technetium-based radiopharmaceutical, as well as other radiopharmaceuticals and ultrasound contrast media.
December 4, 2007
Neoprobe, Cardinal Health ink distribution deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has signed a distribution agreeement with healthcare products firm Cardinal Health, also of Dublin, for the marketing and distribution of its Lymphoseek radiopharmaceutical through Cardinal's network of more than 150 nuclear pharmacies.
November 27, 2007
IBA, PETLinQ acquire SourceMedical's radiology division
By AuntMinnie.com staff writers
IBA Molecular, North America and PETLinQ have acquired the radiology division of SourceMedical. The acquisition will expand the companys' product line to include the SourceRad RIS and billing system.
November 25, 2007
New contrast agent could replace some nuclear stress testing with echo
By Eric Barnes
Researchers in the U.K. believe that an investigative echocardiography contrast agent could soon be used to replace nuclear cardiography stress exams for the initial detection of coronary artery disease. Their preliminary results of two trials suggest that perfusion stress echocardiography is as accurate as nuclear stress testing for detecting coronary artery disease.
November 21, 2007
Previous Page
Page 330 of 438
Next Page